Oct 03, 2017

House Should Approve Right To Try As Soon As Possible

Post by Geoff Holtzman

Arlington, VA — The U.S. House Committee on Energy and Commerce Subcommittee on Health will hold a hearing this morning on national Right To Try legislation, which the U.S. Senate approved back in August.

The measure would allow terminally ill patients who have exhausted all other avenues to gain access to potentially life-saving drugs that have passed the first of three U.S. FDA approval phases, but have yet to receive final approval from the agency.

Freedom Partners Vice President of Policy Nathan Nascimento issued the following statement:

“No American should have to ask the federal government for permission to try to save his or her own life. Right To Try represents hope for terminal patients who have exhausted all other options, and we urge the House to help keep hope alive by quickly approving this critical legislation.”

BACKGROUND

Each year, thousands of terminally ill patients suffer while awaiting final approval for drugs, therapies, and other medical technologies. While the U.S. Food and Drug Administration carries out its three-phase approval process – which can take years and cost billions of dollars – many patients simply want the chance to try treatments that have already demonstrated a level of safety.

To date, 37 states have already signed their own Right to Try legislation into law. However, national legislation would ensure that terminally ill patients in all 50 states, together with their doctors and pharmaceutical manufacturers, are allowed to administer investigational treatments where no alternative exists.

Click here to learn more about why patients need the right to try.